January 18, 2021 – Providence St. Joseph Health, a leading healthcare organization in southern California, recently adopted the EyeArt autonomous artificial intelligence (AI) system in 3 Southern California primary care clinics as part of an innovative initiative to improve the quality of care for diabetic patients.
“Diabetic retinopathy (DR) screening enabled by the EyeArt system in our primary care clinics helps us close an important gap in care for our diabetic patients,” said Christy Mokrohisky, VP for Population Health for Providence St. Joseph Health. “Technology enabling the annual eye examination in our primary care clinics can lead to significant improvements to the quality of care that we deliver to our patients with diabetes.”
The National Committee for Quality Assurance (NCQA), which works with healthcare providers and payers in the United States to improve quality of care, is used by over 90% of U.S. health plans to measure provider performance where several measures are tied to reimbursement. In a 2020 policy update, the NCQA now recognizes an eye exam with AI interpretation as meeting its criteria for diabetes care.